Geneos Wealth Management’s Capital Group Core Balanced ETF CGBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1M Buy
319,852
+39,492
+14% +$1.46M 0.25% 94
2026
Q1
$9.65M Buy
280,360
+10,288
+4% +$368K 0.22% 100
2025
Q4
$9.54M Buy
270,072
+79,018
+41% +$2.76M 0.23% 105
2025
Q3
$6.63M Buy
191,054
+80,637
+73% +$2.75M 0.17% 150
2025
Q2
$3.69M Buy
110,417
+89,936
+439% +$2.84M 0.09% 272
2025
Q1
$634K Buy
20,481
+10,200
+99% +$324K 0.02% 552
2024
Q4
$321K Buy
+10,281
New +$324K 0.01% 689

Other funds holding CGBL

Geneos Wealth Management's CGBL Position: Q2 2026 in Review

Geneos Wealth Management increased its Capital Group Core Balanced ETF (CGBL) stake by 14% in Q2 2026, buying an estimated $1.46M and bringing the position to 319,852 shares worth $12.1M. The position accounts for 0.25% of the portfolio, ranked #94.

Geneos Wealth Management first reported a position in CGBL in Q4 2024 and has held it in 7 quarters since. 360 funds tracked by Wall St. Rank hold CGBL as of Q2 2026.

  • Geneos Wealth Management held 319,852 shares of Capital Group Core Balanced ETF worth $12.1M as of Q2 2026.
  • Geneos Wealth Management bought 39,492 Capital Group Core Balanced ETF shares in Q2 2026, an estimated $1.46M.
  • Capital Group Core Balanced ETF made up 0.25% of Geneos Wealth Management's portfolio in Q2 2026, its #94 holding.
  • Geneos Wealth Management first reported a position in Capital Group Core Balanced ETF in Q4 2024 and has held it in 7 quarters since.
  • 360 funds tracked by Wall St. Rank held Capital Group Core Balanced ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.